BNP Paribas Financial Markets’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-1,887
Closed -$32.5K 3583
2015
Q4
$32.5K Sell
1,887
-258
-12% -$4.44K ﹤0.01% 3081
2015
Q3
$45.2K Sell
2,145
-206
-9% -$4.35K ﹤0.01% 2933
2015
Q2
$116K Buy
2,351
+62
+3% +$3.07K ﹤0.01% 2000
2015
Q1
$179K Buy
2,289
+1,039
+83% +$81.4K ﹤0.01% 1586
2014
Q4
$75.8K Sell
1,250
-5,868
-82% -$356K ﹤0.01% 1589
2014
Q3
$303K Buy
7,118
+4,600
+183% +$196K ﹤0.01% 1452
2014
Q2
$156K Sell
2,518
-4,852
-66% -$300K ﹤0.01% 1552
2014
Q1
$414K Buy
7,370
+7,247
+5,892% +$407K ﹤0.01% 1335
2013
Q4
$6.91K Sell
123
-2,461
-95% -$138K ﹤0.01% 2413
2013
Q3
$158K Sell
2,584
-822
-24% -$50.4K ﹤0.01% 1996
2013
Q2
$199K Buy
+3,406
New +$199K ﹤0.01% 2011